Accuray to Host Analyst Event at the American Society of Radiation Oncology Meeting on September 29, 2025

11.09.25 22:10 Uhr

Werte in diesem Artikel
Aktien

1,41 EUR -0,08 EUR -5,37%

Event Will Feature Global KOLs Sharing Their Perspectives on the Role of Adaptive Radiotherapy in Radiation Medicine

MADISON, Wis., Sept. 11, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company will host a discussion with analysts and investors on Monday, September 29, 2025, in conjunction with the American Society of Radiation Oncology (ASTRO) Annual Meeting in San Francisco, California. The event will take place in person at the ASTRO meeting and on a virtual platform, with presentations beginning at 1:30 pm PT (4:30 pm ET).

Accuray Incorporated (PRNewsFoto/Accuray Incorporated) (PRNewsFoto/Accuray Incorporated)

Analysts participating in the event will have a unique opportunity to hear first-hand from global thought leaders who will share their perspectives on the role of adaptive radiotherapy in radiation medicine. Topics include:

  • The Adaptive Radiotherapy Spectrum & Programmatic Vision
  • Integration of Adaptive Radiotherapy into Practice & Workflow Realities
  • Motion Management & Imaging Leadership: The Global Perspective

Both in-person and virtual guests must register in advance to participate in the Accuray meeting. Please RSVP here by September 25, 2025.

About Accuray
Accuray Incorporated (Nasdaq: ARAY) is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases – while making commonly treatable cases even easier – to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide.

Investor Contact
Aman Patel, CFA
Investor Relations, ICR Healthcare
+1 (443) 450-4191
aman.patel@westwicke.com

Media Contact
Beth Kaplan
Public Relations Director, Accuray
bkaplan@accuray.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-host-analyst-event-at-the-american-society-of-radiation-oncology-meeting-on-september-29-2025-302554133.html

SOURCE Accuray Incorporated

In eigener Sache

Übrigens: Accuray und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Accuray

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Accuray

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Accuray IncShs

Wer­bung

Analysen zu Accuray IncShs

DatumRatingAnalyst
30.11.2017Accuray BuyLake Street
22.12.2015Accuray Sector PerformRBC Capital Markets
01.05.2015Accuray BuyDougherty & Company LLC
12.01.2015Accuray OutperformNorthland Capital
06.11.2007Accuray günstig bewertetGlobal Biotech Investing
DatumRatingAnalyst
30.11.2017Accuray BuyLake Street
01.05.2015Accuray BuyDougherty & Company LLC
12.01.2015Accuray OutperformNorthland Capital
06.11.2007Accuray günstig bewertetGlobal Biotech Investing
DatumRatingAnalyst
22.12.2015Accuray Sector PerformRBC Capital Markets
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Accuray IncShs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen